Trial Profile
Effect of Linagliptin and insulin on metabolic control, insulin dose and hypoglycemia in uncontrolled type 1 diabetes mellitus patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Jul 2017
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary) ; Insulin
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 19 Jul 2017 New trial record
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association